Literature DB >> 10984530

Identification of a nuclear domain with deacetylase activity.

M Downes1, P Ordentlich, H Y Kao, J G Alvarez, R M Evans.   

Abstract

Here, we describe the identification and characterization of a nuclear body (matrix-associated deacetylase body) whose formation and integrity depend on deacetylase activity. Typically, there are 20-40 0.5-microM bodies per nucleus, although the size and number can vary substantially. The structure appears to contain both class I and the recently described class II histone deacetylases (HDAC)5 and 7 along with the nuclear receptor corepressors SMRT (silencing mediator for retinoid and thyroid receptor) and N-CoR (nuclear receptor corepressor). Addition of the deacetylase inhibitors trichostatin A and sodium butyrate completely disrupt these nuclear bodies, providing a demonstration that the integrity of a nuclear body is enzyme dependent. We demonstrate that HDAC5 and 7 can associate with at least 12 distinct proteins, including several members of the NuRD and Sin3A repression complexes, and appear to define a new but related complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984530      PMCID: PMC27024          DOI: 10.1073/pnas.97.19.10330

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Association of RNA with the cytoskeleton and the nuclear matrix.

Authors:  E G Fey; D A Ornelles; S Penman
Journal:  J Cell Sci Suppl       Date:  1986

2.  A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.

Authors:  J A Dyck; G G Maul; W H Miller; J D Chen; A Kakizuka; R M Evans
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 3.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

Review 4.  Multiple functions of dynamic histone acetylation.

Authors:  J R Davie; M J Hendzel
Journal:  J Cell Biochem       Date:  1994-05       Impact factor: 4.429

5.  The nuclear matrix: three-dimensional architecture and protein composition.

Authors:  D G Capco; K M Wan; S Penman
Journal:  Cell       Date:  1982-07       Impact factor: 41.582

6.  Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.

Authors:  L Nagy; H Y Kao; D Chakravarti; R J Lin; C A Hassig; D E Ayer; S L Schreiber; R M Evans
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

7.  Histone deacetylase activity of Rpd3 is important for transcriptional repression in vivo.

Authors:  D Kadosh; K Struhl
Journal:  Genes Dev       Date:  1998-03-15       Impact factor: 11.361

8.  A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.

Authors:  C A Hassig; J K Tong; T C Fleischer; T Owa; P G Grable; D E Ayer; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  A retinoblastoma-binding protein related to a negative regulator of Ras in yeast.

Authors:  Y W Qian; Y C Wang; R E Hollingsworth; D Jones; N Ling; E Y Lee
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

10.  A histone deacetylase corepressor complex regulates the Notch signal transduction pathway.

Authors:  H Y Kao; P Ordentlich; N Koyano-Nakagawa; Z Tang; M Downes; C R Kintner; R M Evans; T Kadesch
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more
  48 in total

1.  EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Authors:  Daniel Portal; Bo Zhao; Michael A Calderwood; Thomas Sommermann; Eric Johannsen; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Higher order arrangement of the eukaryotic nuclear bodies.

Authors:  I-Fan Wang; Narsa M Reddy; C-K James Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-02       Impact factor: 11.205

3.  Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.

Authors:  Michael L Goodson; Brenda J Mengeling; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor.

Authors:  G B Potter; G M Beaudoin; C L DeRenzo; J M Zarach; S H Chen; C C Thompson
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

Review 5.  Quantitative imaging of protein interactions in the cell nucleus.

Authors:  Ty C Voss; Ignacio A Demarco; Richard N Day
Journal:  Biotechniques       Date:  2005-03       Impact factor: 1.993

6.  Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus.

Authors:  Ty C Voss; Ignacio A Demarco; Cynthia F Booker; Richard N Day
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

Review 7.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 8.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

9.  Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.

Authors:  Eric D Jensen; Tania M Schroeder; Jaclyn Bailey; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2008-03       Impact factor: 6.741

Review 10.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.